GNMT and metabolic dysfunction-associated steatohepatitis: Furthermore, GNMT has been shown to be reduced during hepatic injury and multiple genetic analyses of human patients have found that GNMT gene expression is repressed in both NASH and hepatocellular carcinoma patients [9,10,11,12,13].